- Home
- AESI vs BEAM Comparison
AESI vs BEAM Comparison
Compare AESI & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AESI
- BEAM
- Stock Information
- Founded
- AESI 2017
- BEAM 2017
- Country
- AESI United States
- BEAM United States
- Employees
- AESI N/A
- BEAM N/A
- Industry
- AESI Metal Fabrications
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AESI Industrials
- BEAM Health Care
- Exchange
- AESI Nasdaq
- BEAM Nasdaq
- Market Cap
- AESI 1.7B
- BEAM 1.7B
- IPO Year
- AESI 2023
- BEAM 2020
- Fundamental
- Price
- AESI $11.84
- BEAM $16.64
- Analyst Decision
- AESI Buy
- BEAM Strong Buy
- Analyst Count
- AESI 8
- BEAM 10
- Target Price
- AESI $18.81
- BEAM $48.56
- AVG Volume (30 Days)
- AESI 1.5M
- BEAM 2.5M
- Earning Date
- AESI 08-04-2025
- BEAM 08-05-2025
- Dividend Yield
- AESI 8.45%
- BEAM N/A
- EPS Growth
- AESI N/A
- BEAM N/A
- EPS
- AESI 0.12
- BEAM N/A
- Revenue
- AESI $1,162,039,000.00
- BEAM $60,272,000.00
- Revenue This Year
- AESI $10.61
- BEAM N/A
- Revenue Next Year
- AESI $3.94
- BEAM $17.18
- P/E Ratio
- AESI $102.39
- BEAM N/A
- Revenue Growth
- AESI 49.18
- BEAM N/A
- 52 Week Low
- AESI $10.92
- BEAM $13.53
- 52 Week High
- AESI $26.86
- BEAM $35.25
- Technical
- Relative Strength Index (RSI)
- AESI 43.73
- BEAM 38.79
- Support Level
- AESI $10.92
- BEAM $15.60
- Resistance Level
- AESI $11.58
- BEAM $18.17
- Average True Range (ATR)
- AESI 0.53
- BEAM 0.93
- MACD
- AESI -0.00
- BEAM -0.20
- Stochastic Oscillator
- AESI 40.71
- BEAM 29.89
About AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the most active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.